Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in...

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Diffuse Large B-cell Lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma (NHL), characterized by significant genetic and phenotypic heterogeneity.
• Understanding DLBCL's cellular diversity and intratumoral heterogeneity is crucial for elucidating disease progression and developing novel therapies.

Purpose of the Study:

• To comprehensively analyze the transcriptomic landscape of DLBCL at the single-cell level.
• To identify distinct malignant and immune cell subpopulations and their interactions within the DLBCL tumor microenvironment (TME).
• To develop a prognostic model for DLBCL patient outcomes.

Main Methods:

• Single-cell RNA sequencing was performed on DLBCL and reactive lymph node samples.
• Differential gene expression analysis was used to identify key genes.
• Cell communication analysis was employed to map intercellular interactions.
• A prognostic model was constructed based on identified gene signatures.

Main Results:

• Distinct malignant and immune cell subpopulations were identified in DLBCL, demonstrating high inter-tumor heterogeneity.
• Tumor-infiltrating regulatory CD4+ T cells exhibited immunosuppressive functions, while exhausted CD8+ T cells showed high expression of exhaustion markers.
• Complex cell-cell communication networks between malignant cells and other TME components were elucidated.
• A prognostic model was developed to monitor DLBCL patient prognosis.

Conclusions:

• This study provides a detailed transcriptional characterization of malignant B cells and the TME in DLBCL.
• New insights into DLBCL's tumor heterogeneity and potential therapeutic strategies were uncovered.
• The developed prognostic model aids in predicting patient outcomes.